# A Study to Determine the Relative Oral Bioavailability of Single Dose Administration of TMC207, Under Fed and Fasted Conditions in Healthy Participants

> **NCT00946842** · PHASE1 · COMPLETED · sponsor: **Tibotec BVBA** · enrollment: 28 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Treatment A
- **DRUG:** Treatment B
- **DRUG:** Treatment C
- **DRUG:** Treatment D
- **DRUG:** Treatment E
- **DRUG:** Treatment F

## Key facts

- **NCT ID:** NCT00946842
- **Lead sponsor:** Tibotec BVBA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2013-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00946842

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00946842, "A Study to Determine the Relative Oral Bioavailability of Single Dose Administration of TMC207, Under Fed and Fasted Conditions in Healthy Participants". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT00946842. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*